Teva faces almost 300 lawsuits stemming from a hepatitis C outbreak three years ago in southern Nevada, the company said in a regulatory filing last month. Photographer: Adam Reynolds/Bloomberg

Teva faces almost 300 lawsuits stemming from a hepatitis C outbreak three years ago in southern Nevada, the company said in a regulatory filing last month. Photographer: Adam Reynolds/Bloomberg

February 21, 2012
Article Teva Is Said to Pay $250 Million to End Nevada Colonoscopy Hepatitis Cases
Back to Home